# Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension

> **NCT01987323** · PHASE1,PHASE2 · COMPLETED · sponsor: **Singapore Eye Research Institute** · enrollment: 6 (actual)

## Conditions studied

- Ocular Hypertension

## Interventions

- **DRUG:** Subconjunctival injection of liposomal latanoprost

## Key facts

- **NCT ID:** NCT01987323
- **Lead sponsor:** Singapore Eye Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987323, "Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01987323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*